Virtek to develop FONA (fibre-optic nucleic acid) genetic test
This article was originally published in Clinica
Executive Summary
Virtek Vision International is developing a rapid, disposable genetic test, based on fibre-optic nucleic acid (FONA) biosensor technology, that can provide quantifiable results for point-of-care use.